Pictet-Europe Index R dy GBPRegister to Unlock Ratings |
Performance History | 31/08/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 1.9 | 16.9 | -4.6 | 12.7 | 8.3 | |
+/-Cat | -2.5 | 1.6 | 3.7 | 1.1 | 0.8 | |
+/-B’mrk | -0.7 | -0.7 | -0.1 | -0.5 | -1.0 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
NAV 25/09/2024 | GBP 166.49 | |
Day Change | 0.20% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
IA (formerly IMA) Sector | - | |
ISIN | LU0396226531 | |
Fund Size (Mil) 25/09/2024 | EUR 929.10 | |
Share Class Size (Mil) 25/09/2024 | GBP 0.34 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 18/04/2024 | 0.74% |
Investment Objective: Pictet-Europe Index R dy GBP |
To achieve a performance comparable to the reference index. The Fund aims for the full physical replication of the MSCI Europe Index (the “Benchmark Index”). |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Jean−Michel Piuz 01/07/2007 | ||
Roland Riat 23/04/1999 | ||
Inception Date 30/10/2008 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Pictet-Europe Index R dy GBP | 31/07/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 3.86 |
ASML Holding NV | Technology | 3.28 |
Nestle SA | Consumer Defensive | 2.42 |
AstraZeneca PLC | Healthcare | 2.20 |
Shell PLC | Energy | 2.09 |
Increase Decrease New since last portfolio | ||
Pictet-Europe Index R dy GBP |